Egor V. Shorikov

Yekaterinburg, SVE, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Combination of chemotherapy and all-trans retinoic acid for the treatment KMT2A-rearranged infant acute lymphoblastic leukemia. Results of the MLL-Baby trial.

Combination of chemotherapy and all-trans retinoic acid for the treatment KMT2A-rearranged infant acute lymphoblastic leukemia. Results of the MLL-Baby trial.

Journal: Leukemia

Published: June 01, 2023

Genetic characteristics and treatment outcome in infants with KMT2A germline B-cell precursor acute lymphoblastic leukemia: Results of MLL-Baby protocol.

Genetic characteristics and treatment outcome in infants with KMT2A germline B-cell precursor acute lymphoblastic leukemia: Results of MLL-Baby protocol.

Journal: Pediatric blood & cancer

Published: August 26, 2022

Suppressed miR-128-3p combined with TERT overexpression predicts dismal outcomes for neuroblastoma.

Suppressed miR-128-3p combined with TERT overexpression predicts dismal outcomes for neuroblastoma.

Journal: Cancer biomarkers : section A of Disease markers

Published: May 31, 2022

Incidence and prognostic value of central nervous system involvement in infants with B-cell precursor acute lymphoblastic leukemia treated according to the MLL-Baby protocol.

Incidence and prognostic value of central nervous system involvement in infants with B-cell precursor acute lymphoblastic leukemia treated according to the MLL-Baby protocol.

Journal: Pediatric blood & cancer

Published: April 29, 2022

Comparison of minimal residual disease measurement by multicolour flow cytometry and PCR for fusion gene transcripts in infants with acute lymphoblastic leukaemia with KMT2A gene rearrangements.

Comparison of minimal residual disease measurement by multicolour flow cytometry and PCR for fusion gene transcripts in infants with acute lymphoblastic leukaemia with KMT2A gene rearrangements.

Journal: British journal of haematology

Published: October 12, 2021

Prognostic value of minimal residual disease measured by fusion-gene transcript in infants with KMT2A-rearranged acute lymphoblastic leukaemia treated according to the MLL-Baby protocol.

Prognostic value of minimal residual disease measured by fusion-gene transcript in infants with KMT2A-rearranged acute lymphoblastic leukaemia treated according to the MLL-Baby protocol.

Journal: British journal of haematology

Published: October 02, 2020

Prognostic value of minimal residual disease measured by flow-cytometry in two cohorts of infants with acute lymphoblastic leukemia treated according to either MLL-Baby or Interfant protocols.

Prognostic value of minimal residual disease measured by flow-cytometry in two cohorts of infants with acute lymphoblastic leukemia treated according to either MLL-Baby or Interfant protocols.

Journal: Leukemia

Published: December 27, 2019

Prognostic value of initial bone marrow disease detection by multiparameter flow cytometry in children with neuroblastoma.

Prognostic value of initial bone marrow disease detection by multiparameter flow cytometry in children with neuroblastoma.

Journal: Journal of cancer research and clinical oncology

Published: September 25, 2018

Prospective investigation of applicability and the prognostic significance of bone marrow involvement in patients with neuroblastoma detected by quantitative reverse transcription PCR.

Prospective investigation of applicability and the prognostic significance of bone marrow involvement in patients with neuroblastoma detected by quantitative reverse transcription PCR.

Journal: Pediatric blood & cancer

Published: February 09, 2018

THE COMPARISON OF RESULTS OF DETECTION OF MINIMAL RESIDUAL DISEASE IN PERIPHERAL BLOOD AND MARROW IN CHILDREN OF THE FIRST YEAR OF LIFE WITH ACUTE LYMPHOBLASTIC LEUCOSIS

THE COMPARISON OF RESULTS OF DETECTION OF MINIMAL RESIDUAL DISEASE IN PERIPHERAL BLOOD AND MARROW IN CHILDREN OF THE FIRST YEAR OF LIFE WITH ACUTE LYMPHOBLASTIC LEUCOSIS

Journal: Klinicheskaia laboratornaia diagnostika

Published: July 21, 2015

Prognostic value of bone marrow lesions in children with neuroblastoma detected by flow cytometry

Prognostic value of bone marrow lesions in children with neuroblastoma detected by flow cytometry

Journal: Voprosy onkologii

Published: January 02, 2015

Prognostic value of the determination of bone marrow lesion in patients with neuroblastoma based on the gene PHOX2B and TH expression

Prognostic value of the determination of bone marrow lesion in patients with neuroblastoma based on the gene PHOX2B and TH expression

Journal: Voprosy onkologii

Published: June 13, 2014

Showing 1-12 of 14

Last Updated: 09/26/2026